|
|
楼主 |
发表于 2025-5-3 20:37:44
|
显示全部楼层
本帖最后由 NatureBoy 于 2025-5-3 20:41 编辑 . w4 @/ ]4 S& c0 k# a
6 ~6 z: `, ~* |1 V今年ASCO大会，肿瘤内科三大BU——头颈肿瘤、胸部肿瘤、腹部肿瘤中表现相对好的是头颈肿瘤BU，腹部肿瘤和生物治疗科今年哑火了: r, \! b8 R7 {0 e0 [) ]8 ~) d3 Z% B
* n/ f) ?8 K: h9 O
头颈肿瘤BU入选ASCO 2025的研究
4 K7 e' U( z0 r4 Y, n. e" FHot flashes and night sweats in women with breast cancer: Prevalence and severity of symptoms.
* E$ w. w# C5 c! J, B肿瘤内科-头颈肿瘤科姜愚团队5 q6 O$ r: w& i& ?8 L% o
: f; U, Q0 @4 [0 KNeoadjuvant immunotherapy in combination with chemotherapy in resectable locally advanced head and neck squamous cell carcinoma: A randomized, open label, phase II clinical trial.
, W, u7 U' f2 Z9 _) X( o肿瘤内科-头颈肿瘤科刘磊团队
* _1 n. I$ ]0 k9 F9 L! c4 A! L1 l$ z
A phase II study of AK117 combined with cetuximab or AK104 in the treatment of recurrent or metastatic head and neck squamous cell carcinoma after the failure of PD-1 (L1) inhibitors and/or platinum-based therapy.0 k" j0 a# j1 \9 {% ?
肿瘤内科-头颈肿瘤科刘磊团队/ I) u Q) A1 z3 O/ ^
2 f7 u3 ^7 `! X7 d5 A- M: w6 R! T1 i
A phase II randomized trial of nano-crystalline megestrol acetate for nutritional improvement in postoperative head and neck squamous cell carcinoma undergoing radiotherapy.
# [6 A& Z Z5 [/ C" U肿瘤内科-头颈肿瘤科刘磊团队) F8 x, w0 g2 \' W
. M( Q) b& ^! ^6 Gribulin plus anlotinib in advanced soft tissue sarcoma (ERAS): Updates on efficacy and biomarkers.- }" Q4 i q0 Z# E
肿瘤内科-头颈肿瘤科姜愚团队
0 @9 e7 R6 _, r1 ? |
|
[复制链接]
发表于 2025-5-2 09:58:22
5 [: z) u/ [( T6 U: a: \/ a